Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A

2(40.0%)

Early Phase 1

1(20.0%)

Phase 2

1(20.0%)

Phase 1

1(20.0%)

5Total

N/A(2)

Early Phase 1(1)

Phase 2(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT02627508Phase 2Completed

Pilot Trial of Pregnenolone in Autism

Role: collaborator

NCT04146428Not ApplicableCompleted

Evaluating BOSCC and ELSA as Outcome Measures in the Context of a JASPER Intervention Trial

Role: collaborator

NCT03492060Recruiting

Longitudinal Study of Neurogenetic Disorders

Role: collaborator

NCT01238250Recruiting

Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight

Role: collaborator

NCT02856061Not ApplicableCompleted

Tracking Intervention Effects With Eye Tracking

Role: collaborator

NCT02278328Early Phase 1Completed

MEG Study of Acute STX209 Effects in ASD

Role: collaborator

NCT01040221Phase 1Completed

Trichuris Suis Ova in Autism Spectrum Disorders

Role: collaborator

NCT01784744Completed

Hyperthermia and the Amelioration of Autism Symptoms

Role: collaborator

All 8 trials loaded